Benzodiazepines for psychosis-induced aggression or agitation

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Gillies, Donna ^a   Beck, Alison ^b   McCloud, Annie ^c   Rathbone, John ^d  

^a CUMBERLAND HOSPITAL   (Australia)

^b SPRINGFIELD HOSPITAL   (United Kingdom)

^c EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d INSTITUTE OF MENTAL HEALTH   (United Kingdom)

Author keywords

Acute disease; Antipsychotic agents *therapeutic use ; Benzodiazepines *therapeutic use ; Drug therapy, combination; Emergency treatment; Lorazepam therapeutic use ; Psychotic disorders *drug therapy ; Randomized controlled trials as topic

Indexed keywords

AMOBARBITAL; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; DIAZEPAM; DROPERIDOL; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; NITRAZEPAM; PARALDEHYDE; PLACEBO; PROMETHAZINE;

AGGRESSION; AGITATION; ANTICHOLINERGIC EFFECT; CLINICAL TRIAL; COCHRANE LIBRARY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; PSYCHOSIS; REVIEW; SEDATION;

EID: 77950120798     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003079.pub2     Document Type: Review

References (53)

1. Barbee 1992 {published data only} * Barbee JG, Mancuso DM, Freed CR, Todorov AA. Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia [published erratum appears in Am J Psychiatry 1992 Aug;149(8): 1129] [see comments]. American Journal of Psychiatry 1992;149: 506-10.
2. Battaglia 1997 {published data only} * Battaglia J, Moss S, Rush J, Kang J, Mendoza R, Leedom L. Haloperidol, lorazepam, or both for psychotic agitation?A multicenter, prospective, double-blind, emergency department study. American Journal of Emergency Medicine 1997;15:335-40.
3. Bienek 1998 {published data only} * Bieniek SA, Ownby RL, Penalver A, Dominguez RA. A doubleblind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 1998;18:57-62.
4. Chouinard 1993 {published data only} * Chouinard G, Annable L, Turnier L, Holobow N, Szkrumelak N. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms [see comments]. Canadian Journal of Psychiatry 1993;38:S114-S121.
5. Dorevitch 1999 {published data only} * Dorevitch A, Katz N, Zemishlany Z, Aizenberg D, Weizman A. Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior. American Journal of Psychiatry 1999;156:142-4.
6. Foster 1997 {published data only} * Foster S, Kessel J, Berman ME, Simpson GM. Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. International Clinical Psychopharmacology 1997;12:175-9.
7. Lerner 1979 {published data only} * Lerner Y, Lwow E, Levitin A, Belmaker RH. Acute high-dose parenteral haloperidol treatment of psychosis. American Journal of Psychiatry 1979;136:1061-4.
8. Meehan 2001 {published data only} * Meehan KZ. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. Journal of Clinical Psychopharmacology 2001;21:389-97.
9. Salzman 1991 {published data only} * Salzman C, Solomon D, Miyawaki E, Glassman R. Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. Journal of Clinical Psychiatry 1991;52(4): 177-80.
10. Solomon 1990 {published data only} * Solomon DA, Miyawaki E, Salzman C. Benzodiazepine augmentation of the treatment of disruptive psychotic behavior. [Review] [46 refs]. Progress in Drug Research 1990;35:139-49.
11. Subramaney 1998 {published data only} * Subramaney U, Brook S, Berk M. A prospective randomised double-blind controlled study of the efficacy of lorazepam versus clothiapine in the control of acutely behaviourally disturbed patients. South African Medical Journal 1998;88:307-10.
12. Arana 1986 {published data only} * Arana GW, Ornsteen ML, Kanter F, Friedman HL, Greenblatt DJ, Shader RI. The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings. Psychopharmacology Bulletin 1986;22:77-87.
13. Garza-Trevino 1989 {published data only} * Garza-Trevino ES, Hollister LE, Overall JE, Alexander WF. Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation [see comments]. American Journal of Psychiatry 1989;146:1598-601.
14. Lenox 1992 {published data only} * Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. Journal of Clinical Psychiatry 1992;53:47-52.
15. Nestoros 1982 {published data only} * Nestoros JN. Diazepam in high doses is effective in schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry 1982; 6:513-6.
16. TREC 2003 {published data only} TREC Collaborative Group. Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. BMJ 2003;327 (27 (September)):1-6.
17. TREC 2004 {published data only} Alexander J, Tharyan P, Adams CE, John T, Mol C, Philip J. Rapid tranquilisation of violent or agitated patients in a psychiatric emergancy setting: a pragmatic randomised trial of intramuscular lorazepam versus haloperidol plus promethazine. British Journal of Psychiatry 2004;185:63-9.
18. Veser 2002 {published data only} Veser F, Zealburg J, Veser B, Zhu Y, Gharabawi G. Oral risperidone in the management of agitated behavior in emergency settings. Journal of the European College of Neuropsychopharmacology 2002;12 (Suppl 3):S313.
19. Wyant 1990 {published data only} * Wyant M, Diamond BI, O'Neal E, Sloan A. The use of midazolam in acutely agitated psychiatric patients. Psychopharmacology Bulletin, 29th Annual Meeting of the New Clinical Drug Evaluation Unit. 1990; Vol. 26:126-9.
20. Yang 2003 {published data only} Yang X, Wang Z, Ling Z. A randomly controlled comparison of risperidone added with intramuscular clonazepam in the treatment of excitement of schizophrenia. Shanghai Archives of Psychiatry 2003;15(2):98-9.
21. Alderson 2004 Alderson P, Green S, Higgins JPT. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. Cochrane Database of Systematic Reviews 2004, Issue 1. [: In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd]
22. Altman 1996 Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
23. Battaglia 1997 Battaglia J, Moss S, Rush J, Kang J, Mendoza R, Leedom L. Haloperidol, lorazepam, or both for psychotic agitation?A multicenter, prospective, double-blind, emergency department study. American Journal of Emergency Medicine 1997;15(4):335-40.
24. Binder 1999 Binder RL, McNiel DE. Emergency psychiatry: contemporary practices in managing acutely violent patients in 20 psychiatric emergency rooms. Psychiatric Services 1999;50(12):1553-4.
25. Bland 1997 Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
26. Csernansky 1988 Csernansky JG, Riney SJ, Lombrozo L, Overall JE, Hollister LE. Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms. Archives of General Psychiatry 1988;45(7):655-9.
27. Cunnane 1994 Cunnane JG. Drug management of disturbed behaviour by psychiatrists. Psychiatric Bulletin 1994;18:138-9.
28. Cure 2001 Cure S, Carpenter S. Droperidol for acute psychosis. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD002830]
29. Divine 1992 Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623-9.
30. Donner 2002 Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971-80.
31. Dubin 1988 Dubin WR. Rapid tranquilization: antipsychotics or benzodiazepines?. Journal of Clinical Psychiatry 1988;49 (Supplement):5-12.
32. Egger 1997 Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
33. Extein 1980 Extein I. Psychopharmacology in psychiatric emergencies. International Journal of Psychiatry in Medicine 1980;10(3):189-204.
34. Fava 1997 Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatric Clinics of North America 1997;20(2):427- 51.
35. Gulliford 1999 Gulliford MC. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-83.
36. Guy 1970 Guy W, Bonato RR, eds. Clinical Global Impressions. In: Manual for the ECDEU Assessment Battery 2. Rev ed. National Institute of Mental Health, 1970.
37. Huf 2000 Huf G, Countino E, Adams CE. A survey of rapid tranquillisation in psychiatric emergency rooms of Rio de Janeiro. manuscript in preparation 2000.
38. Joy 2001 Joy CB, Adams CE, Lawrie SM. Haloperidol versus placebo for schizophrenia. Cochrane Database of Systematic reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD003082.pub2]
39. Kay 1987 Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987;13: 261-76.
40. Levy 1996 Levy RH. Sedation in acute and chronic agitation. Pharmacotherapy 1996;16(6 pt 2):152S-9S; 166S-168S.
41. Lorr 1963 Lorr M, Klett CJ, McNair DM, Lasky JJ. Inpatient Multidimensional Psychiatric Scale. Palo Alto: Consulting Psychologists Press, 1963.
42. Marshall 2000 Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52.
43. Mendelson 1992 Mendelson WB. Clinical distinctions between long-acting and short-acting benzodiazepines. Journal of Clinical Psychiatry 1992;53 (Supplement):4-7; discussion 8-9.
44. Moher 2001 Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-91.
45. Overall 1962 Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports 1962;10:799-812.
46. Pilowsky 1992 Pilowsky LS, Ring H, Shine PJ, Battersby M, Lader M. Rapid tranquillisation. A survey of emergency prescribing in a general psychiatric hospital. British Journal of Psychiatry 1992;160:831- 5.
47. Stimmel 1996 Stimmel GL. Benzodiazepines in schizophrenia. Pharmacotherapy 1996;16(6 pt 2):148S-51S; 166S-8S.
48. TREC 2004 Alexander J, Tharyan P, Adams CE, John T, Mol C, Philip J. Rapid tranquilisation of violent or agitated patients in a psychiatric emergancy setting: a pragmatic randomised trial of intramuscular lorazepam versus haloperidol plus promethazine. British Journal of Psychiatry 2004;185:63-9.
49. Ukoumunne 1999 Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1-75.
50. Wolkowitz 1986 Wolkowitz OM, Pickar D, Doran AR, Breier A, Tarell J, Paul SM. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia. American Journal of Psychiatry 1986;143(1):85-7.
51. Wolkowitz 1989 Wolkowitz OM, Breier A, Doran A, Lucas P, Kelsoe J, Paul SM. Alprazolam augmentation of neuroleptics in schizophrenia. American Journal of Psychiatry 1989;146(8):1087-8.
52. Wolkowitz 1991 Wolkowitz OM, Pickar D. Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. American Journal of Psychiatry 1991;148(6):714-26.
53. Yudofsky 1986 Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the Objective Rating of Verbal and Physical Aggression. American Journal of Psychiatry 1986;143(1): 35-9.